Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients Undergoing Myocardial Perfusion Imaging (ASSUAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01250496
Recruitment Status : Completed
First Posted : November 30, 2010
Last Update Posted : November 28, 2012
Information provided by (Responsible Party):
Rami Doukky, Rush University Medical Center

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : September 2011
  Study Completion Date : September 2011

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 29, 2012 December 31, 2012
2 January 4, 2013 February 12, 2013
3 May 21, 2013  
4 June 21, 2013 July 30, 2013
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):